Interindividual differences in chlorthalidone concentration in plasma and red cells of man after single and multiple doses.
A gas chromatographic method has been employed to determine chlorthalidone in plasma and whole blood after therapeutic doses. Radioactively labelled chlorthalidone was used for in vitro studies of the uptake of chlorthalidone from plasma by red blood cells. Chlorthalidone was markedly concentrated in red cells and as a compartment they would account for at least 30% of total drug in the body after multiple doses. The ratio between the plasma and red cell concentration of chlorathidone varied between individuals. After a single oral dose of 50 mg in 6 healthy volunteers chlorthalidone was eliminated with a half-life of 51 to 89 hours. The apparent volume of distribution varied between 3 and 13 1/kg and the clearance between 53 and 145 ml/min. The mean steady-state plasma concentrations during treatment with a standard dose of 50 mg daily (n = 10) varied 5-fold between individuals. During the steady state approximately 50% of the daily dose was excreted unchanged in the urine during 24 hrs. The plasma levels observed in patients were higher than those preducted from the single oral dose studies in healthy volunteers.
D000328:Adult; D000368:Aged; D001798:Blood Proteins / Q000378:metabolism; D002752:Chlorthalidone / Q000008:administration & dosage / Q000097:blood*; D002849:Chromatography, Gas; D004334:Drug Administration Schedule; D004912:Erythrocytes / Q000378:metabolism*; D006207:Half-Life; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D008657:Metabolic Clearance Rate; D008722:Methods; D008875:Middle Aged; D010949:Plasma / Q000378:metabolism*; D011485:Protein Binding
D001798:Blood Proteins; D002752:Chlorthalidone